Form4insider filings, from the source

SEC Form 5 · accession 0001225208-19-002199

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 31, 2018
Accepted (ET)
Feb 11, 2019 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 1, 2018G0$0.00D45,402IBy Ltd Partnership (NEST)
Common StockF3holding———9,000D
Common StockF4holding———921,610IBy Ltd Partnership (SHV)
Common StockF5holding———449,053IBy Trust (Trustees)

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses